En Es
Categories

Industry News

Roche to Acquire Genmark Diagnostics to Access Novel Technology to Test for Pathogens with One Patient Sample

By Labmedica International staff writers
16 Mar 2021

IllustrationRoche (Basel, Switzerland) and GenMark Diagnostics, Inc. (Carlsbad, CA, USA) have entered into a definitive merger agreement for Roche to fully acquire GenMark which provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample.

GenMark’s syndromic panel testing portfolio will complement Roche’s current molecular diagnostics portfolio and the Roche global network will enable expanded reach for GenMark’s products. GenMark’s ePlex system drives lab efficiency through streamlined order-to-reporting workflow and enables better patient outcomes by rapidly diagnosing a patient’s symptoms. Infectious diseases are a leading cause of death globally, and earlier detection of the cause of an infection has been shown to improve patient outcomes and improve key hospital initiatives such as antibiotic stewardship and length of stay. GenMark’s Respiratory Pathogen Panels identify the most common viral and bacterial organisms associated with upper respiratory infection, including SARS-CoV-2, complementing Roche’s extensive portfolio of COVID-19 diagnostics solutions.

“Acquiring GenMark Diagnostics will broaden our molecular diagnostics portfolio to include solutions that can provide lifesaving information quickly to patients and their healthcare providers in the fight against infectious diseases,” said Thomas Schinecker, CEO Roche Diagnostics. “Their proven expertise in syndromic panel testing provides faster targeted therapeutic intervention, resulting in improved patient outcomes and reduced hospital stays, and will contribute to Roche’s commitment to helping control infectious diseases and antibiotic resistance. The rapid identification of bloodstream infections and the detection of antimicrobial resistance genes are more essential than ever for hospitals and their patients.”

“As a part of Roche, we can accelerate our mission to enable rapid diagnosis of infectious disease to improve patient outcomes. Together with Roche’s diagnostics healthcare solutions, we will be able to provide a full suite of molecular diagnostic solutions to customers around the world,” said Scott Mendel, CEO of GenMark Diagnostics. “We are thrilled to become a part of Roche and are confident that this is the right path forward for GenMark and our customers.”

Related Links:
Roche
GenMark Diagnostics, Inc.




E-mail Print
FaceBook Twitter Google+ Linked in

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests
More info

More articles about Roche Diagnostics

26 Jan 2021
Roche Renews Partnership with Sysmex to Deliver Hematology Testing Solutions
Under the new framework of a Global Business Partnership Agreement (GBP) signed between Roche (Basel, Switzerland) and Sysmex Corporation (Kobe, Japan), both the companies have renewed their commitment to their long standing Distribution, Sales and Service (DSS) agreement, allowing Roche to continue to distribute Sysmex hematology products, including instruments and reagents.
Read More
13 Jan 2021
Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer
Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient.
Read More
18 Oct 2018
Roche Launches Roche Healthcare Consulting
Roche (Basel, Switzerland) has launched Roche Healthcare Consulting, a specialized consulting service that aims to help leaders in laboratories, hospitals and other healthcare groups optimize their operational, clinical and financial performance.
Read More

Additional news

21 Oct 2021
Global CT Market to Surpass USD 6 Billion by 2025 on Back of AI-Powered Imaging, Says Frost & Sullivan
The global computed tomography (CT) market is expected to register steady growth at a CAGR of 8.1% from USD 4.16 billion in 2020 to USD 6.14 billion by 2025, driven primarily by upgrading of existing scanners to high-end scanners, including artificial intelligence (AI)-powered CT scanners for cancer detection.
Read More
20 Oct 2021
Hologic Acquires Bolder Surgical to Expand Surgical Franchise
Hologic, Inc. (Marlborough, MA, USA) is set to acquire Bolder Surgical (Louisville, CO, USA; www.boldersurgical.com), a provider of advanced energy vessel sealing surgical devices, in a deal that will expand its surgical franchise.
Read More
15 Oct 2021
Biohit’s Innovative GastroPanel Quick Test Receives CE Mark
Biohit Healthcare’s (Helsinki, Finland) GastroPanel Quick Test, the latest innovation in its unique GastroPanel product family, is now CE marked.
Read More
15 Oct 2021
Global Point-of-Care (POC) Testing Market to Reach Nearly USD 80 Billion by 2028 due to Increasing Dominance of Infectious Diseases
The global Point-Of-Care (POC) testing market is projected to grow at a CAGR of 12.3% from USD 31.17 billion in 2020 to USD 78.85 billion by 2028, driven mainly by the increasing dominance of infectious diseases, hematological diseases, cancer, and others.
Read More
13 Oct 2021
Global Digital X-Ray Market to Surpass USD 14 Billion by 2026
The global market for digital X-ray is projected to grow at a CAGR of more than 7% from around USD 9 billion in 2020 to over USD 14 billion by 2026, amidst all the opportunities and challenges in a significantly transformed post COVID-19 marketplace.
Read More
06 Oct 2021
IHF Excellence Award 2021 for Corporate Social Responsibility in Healthcare to Be Sponsored by Seddiqi Holding
Seddiqi Holding (Dubai, UAE), a family-owned and managed group with a diverse portfolio of businesses, will sponsor the IHF 2021 Excellence Award for Corporate Social Responsibility in Healthcare to be awarded at the 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland).
Read More
01 Oct 2021
Global Operating Room Equipment Market Expected to Surpass USD 40 Billion in 2027
The global operating room (OR) equipment market was valued at around USD 30 billion in 2020 and is projected to register a CAGR of 4.2% over the forecast period to surpass USD 40 billion by 2027. The market growth is expected to be driven by a rise in the number of hospitals and investments in OR equipment, growing patient preference for minimal invasive surgeries, and increasing regulatory approvals for OR equipment.
Read More
30 Sep 2021
GE Healthcare Acquires BK Medical to Expand Ultrasound Portfolio into Surgical Visualization
GE Healthcare (Chicago, IL, USA) has entered into an agreement to acquire BK Medical (Peabody, MA, USA) in a deal that is expected to create value by further strengthening BK, including through significant synergies with the benefit of GE’s technology and commercial scale.
Read More
22 Sep 2021
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions